Dmitri V. Debabov
Dmitri V. Debabov publishes mostly in Molecular Biology, Molecular Medicine and Infectious Diseases, on topics such as Antibiotic Resistance in Bacteria, Antimicrobial Resistance in Staphylococcus and Antibiotics Pharmacokinetics and Efficacy.
- World rank
- #2,591,637 of 7,710,434 ranked researchers
- Rank in United States
- #760,548 of 1,627,098
- Works
- 51
- Citations
- 1.9k
- Citations per work
- 37.2
What does Dmitri V. Debabov research?
Dmitri V. Debabov's work is mostly in Biochemistry, Genetics and Molecular Biology (30%), Medicine (16%), Chemistry (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2548.7%
- Life Sciences1529.7%
- Health Sciences815.5%
- Medicine815.5%
- Physical Sciences36.1%
- Chemistry36.1%
- 1Molecular Biology13% of their works
- 2Molecular Medicine12% of their works
- 3Infectious Diseases8% of their works
- 4Pharmacology7% of their works
- 5Organic Chemistry6% of their works
- 6Clinical Biochemistry5% of their works
Research topics
- Antibiotic Resistance in Bacteria
- Antimicrobial Resistance in Staphylococcus
- Antibiotics Pharmacokinetics and Efficacy
- Bacterial Identification and Susceptibility Testing
- Antibiotic Use and Resistance
- Amino Acid Enzymes and Metabolism
- Bacterial biofilms and quorum sensing
- Phenothiazines and Benzothiazines Synthesis and Activities
Which keywords describe Dmitri V. Debabov's research?
The keywords of their largest research topics: Antibiotic Resistance, Antimicrobial Resistance, Epidemiology, ESKAPE Pathogens, Multidrug-Resistant Bacteria, Infectious Diseases, Antibiotic Pharmacokinetics and Critically Ill Patients.
- Phenothiazines
- D-Serine
- Bacteria
- Microorganism Identification
- Global Health
- Staphylococcus aureus
- Critically Ill Patients
- Infectious Diseases
- ESKAPE Pathogens
- Antimicrobial Resistance
- Antibiotic Resistance
- Epidemiology
- Multidrug-Resistant Bacteria
- Antibiotic Pharmacokinetics
- MRSA
- Antimicrobial Stewardship
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- Amino Acid Transporters
- Biofilms
- Biological Activities
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Antibiotic Resistance303 topics
- Antimicrobial Resistance222 topics
- Epidemiology192 topics
- ESKAPE Pathogens171 topic
- Multidrug-Resistant Bacteria171 topic
- Infectious Diseases132 topics
- Antibiotic Pharmacokinetics111 topic
- Critically Ill Patients111 topic
- MRSA111 topic
- Staphylococcus aureus111 topic
- Antimicrobial Stewardship81 topic
- Global Health81 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry81 topic
- Microorganism Identification81 topic
- Amino Acid Transporters51 topic
- Bacteria51 topic
- Biofilms51 topic
- D-Serine51 topic
- Biological Activities41 topic
- Phenothiazines41 topic
Where does Dmitri V. Debabov work?
Dmitri V. Debabov's main affiliation in the publication record is NovaBay Pharmaceuticals (United States), United States.
How many publications and citations does Dmitri V. Debabov have?
OpenAlex counts 51 works and 1,895 citations for Dmitri V. Debabov, an h-index of 21, ranking #2,591,637 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Dmitri V. Debabov. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.